§ 3306 — Schedules of controlled substances

New York § 3306

• Jurisdiction: New York
• Law PBH: Public Health
• Title 1: General Provisions
• Art. 33: Controlled Substances

Text

§ 3306. Schedules of controlled substances. There are hereby\nestablished five schedules of controlled substances, to be known as\nschedules I, II, III, IV and V respectively. Such schedules shall\nconsist of the following substances by whatever name or chemical\ndesignation known:\n Schedule I. (a) Schedule I shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n (b) Opiates. Unless specifically excepted or unless listed in another\nschedule, any of the following opiates, including their isomers, esters,\nethers, salts, and salts of isomers, esters, and ethers, whenever the\nexistence of such isomers, esters, ethers and salts is possible within\nthe specific chemical designation (for purposes of 3-methylfentanyl\nonly, the term isomer includes the optical and geometric isomers):\n (1) Acetyl-alpha-methylfentanyl\n(N-{1-(-methyl-2-phenethyl) -4-piperidinyl} -N-phenylacetamide.\n (2) Acetylmethadol.\n (3) Allylprodine.\n (4) Alphacetylmethadol (except levo- alphacetylmethadol also known as\nlevo-alpha-acetylmethadol, levomethadylacetate or LAAM).\n (5) Alphameprodine.\n (6) Alphamethadol.\n (7) Alpha-methylfentanyl (N-{1-(alpha-methyl-beta-phenyl)\nethyl-4-piperidyl} propionanilide; 1-(1-methyl-2-phenylethyl)\n-4-(N-propanilido) piperidine).\n (8) Alpha-methylthiofentanyl (N-{1-methyl-2)2-thienyl)\nethyl-4-piperidinyl} -N-phenylpropanamide).\n (9) Beta-hydroxyfentanyl\n(N-{1-2 (2-hydroxy-2-phenethyl)- 4-piperidinyl} -N-phenylpropanamide).\n (10) Beta-hydroxy-3-methylfentanyl (other name: N-{1-\n(2-hydroxy-2-phenethyl) -3-methyl -4-piperidinyl} -N-phenylpropanamide.\n (11) Benzethidine.\n (12) Betacetylmethadol.\n (13) Betameprodine.\n (14) Betamethadol.\n (15) Betaprodine.\n (16) Clonitazene.\n (17) Dextromoramide.\n (18) Diampromide.\n (19) Diethylthiambutene.\n (20) Difenoxin.\n (21) Dimenoxadol.\n (22) Dimepheptanol.\n (23) Dimethylthiambutene.\n (24) Dioxaphetyl butyrate.\n (25) Dipipanone.\n (26) Ethylmethylthiambutene.\n (27) Etonitazene.\n (28) Etoxeridine.\n (29) Furethidine.\n (30) Hydroxypethidine.\n (31) Ketobemidone.\n (32) Levomoramide.\n (33) Levophenacylmorphan.\n (34) 3-Methylfentanyl (N-{3-methy1-1- (2- phenylethyl -4-piperidyl}\n-N-phenylpropanamide).\n (35) 3-Methylthiofentanyl (N-{3-methyl-1- (2-thienyl)ethyl\n-4-piperidinyl} -N-phenylpropanamide).\n (36) Morpheridine.\n (37) MPPP (1-methyl -4-phenyl -4-propionoxypiperidine).\n (38) Noracymethadol.\n (39) Norlevorphanol.\n (40) Normethadone.\n (41) Norpipanone.\n (42) Para-fluorofentanyl (N- (4-fluorophenyl) -N-{1- (2-phenethyl)\n-4-piperidinyl} -propanamide.\n (43) PEPAP (1- (-2-phenethyl) -4-phenyl -4-acetoxypiperidine.\n (44) Phenadoxone.\n (45) Phenampromide.\n (46) Phenomorphan.\n (47) Phenoperidine.\n (48) Piritramide.\n (49) Proheptazine.\n (50) Properidine.\n (51) Propiram.\n (52) Racemoramide.\n (53) Thiofentanyl (N-phenyl-N-{1- (2-thienyl) ethyl -4- piperidinyl}\n-propanamide.\n (54) Tilidine.\n (55) Trimeperidine.\n (56) 3,4-dichloro-N-{(1-dimethylamino)cyclohexylmethyl}benzamide.\nSome trade or other names: AH-7921.\n (57) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide. Some trade or\nother names: Acetyl Fentanyl.\n (58) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide. Other name:\nButyryl Fentanyl.\n (59) N-{1-{2-hydroxy-2-(thiophen-2-yl)ethyl}piperidin-4-yl}-N-\nphenylpropionamide. Other name: Beta-Hydroxythiofentanyl.\n (60) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide. Other\nname: Furanyl Fentanyl.\n (61) 3,4-Dichloro-N-{2-(dimethylamino)cyclohexyl}-N-methylbenzamide.\nOther name: U-47700.\n (62) N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide. Other names:\nAcryl Fentanyl or Acryloylfentanyl.\n (63) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide.\nOther names: 4-fluoroisobutyryl fentanyl, para-fluoroisobutyryl\nfentanyl.\n (64) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide.\nOther names: ortho-fluorofentanyl or 2-fluorofentanyl.\n (65) N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carbox-\namide. Other name: tetrahydrofuranyl fentanyl.\n (66) 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide. Other\nname: methoxyacetyl fentanyl.\n (67) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide.\nOther name: cyclopropyl fentanyl.\n (68) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide. Other\nname: para-fluorobutyrylfentanyl.\n (69) N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetam-\nide. Other name: Ocfentanil.\n (70) 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine. Other name: MT-45.\n (71) N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide. Other name:\nValeryl fentanyl.\n (72) N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide.\nOther name: para-methoxybutyryl fentanyl.\n (73) N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide.\nOther name: para-chloroisobutyryl fentanyl.\n (74) N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide. Other name:\nisobutyryl fentanyl.\n (75) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide.\nOther name: cyclopentyl fentanyl.\n (76) (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide. Other\nname: crotonyl fentanyl.\n (77) N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)\npropionamide. Other names: 2'-fluoro ortho-fluorofentanyl; 2'-fluoro\n2-fluorofentanyl.\n (78) N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide. Other\nnames: ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl.\n (79) N-(1-phenethylpiperidin-4-yl)-N, 3-diphenylpropanamide. Other\nnames: beta'-phenyl fentanyl; beta'-phenyl fentanyl; 3-phenylpropanoyl\nfentanyl.\n (80) N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide.\nOther names: thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene\nfentanyl.\n (81) N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide. Other\nnames: beta-Methyl fentanyl; beta-methyl fentanyl.\n (82) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide. Other\nnames: ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl.\n (83) N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide. Other\nname: 4'-methyl acetyl fentanyl.\n (84) 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide.\nOther names: ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl\nfentanyl.\n (85) N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide.\nOther names: para-methylfentanyl; 4-methylfentanyl.\n (86) N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide. Other names:\nphenyl fentanyl; benzoyl fentanyl.\n (87) ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate. Other name:\nFentanyl carbamate.\n (88) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide.\nOther name: ortho-fluoroacryl fentanyl.\n (89) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide.\nOther name: ortho-fluoroisobutyryl fentanyl.\n (90) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide.\nOther name: para-fluoro furanyl fentanyl.\n (91) N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)\nethan-1-amine. Other name: Isotonitazene.\n (92) 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-\nbenzo{d}imidazol-2-one. Other names: Brorphine; 1-{1-{1-(4-bromophenyl)\nethyl}-4-piperidinyl}-1,3-dihydro-2H-benzimidazol-2-one.\n (c) Opium derivatives. Unless specifically excepted or unless listed\nin another schedule, any of the following opium derivatives, its salts,\nisomers, and salts of isomers whenever the existence of such salts,\nisomers, and salts of isomers is possible within the specific chemical\ndesignation:\n (1) Acetorphine.\n (2) Acetyldihydrocodeine.\n (3) Benzylmorphine.\n (4) Codeine methylbromide.\n (5) Codeine-N-oxide.\n (6) Cyprenorphine.\n (7) Desomorphine.\n (8) Dihydromorphine.\n (9) Drotebanol.\n (10) Etorphine (except hydrochloride salt).\n (11) Heroin.\n (12) Hydromorphinol.\n (13) Methyldesorphine.\n (14) Methyldihydromorphine.\n (15) Morphine methylbromide.\n (16) Morphine methylsulfonate.\n (17) Morphine-N-oxide.\n (18) Myrophine.\n (19) Nicocodeine.\n (20) Nicomorphine.\n (21) Normorphine.\n (22) Pholcodine.\n (23) Thebacon.\n (d) Hallucinogenic substances. Unless specifically excepted or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation, which contains any quantity of the following hallucinogenic\nsubstances, or which contains any of its salts, isomers, and salts of\nisomers whenever the existence of such salts, isomers, and salts of\nisomers is possible within the specific chemical designation (for\npurposes of this paragraph only, the term "isomer" includes the optical,\nposition and geometric isomers):\n(EXPLANATION--Within the following chemical designations, character\n symbol substitutions were made from the original text: "@" = Greek\n alpha, "&" = Greek beta, "'" = prime mark and "/\" = triangle.)\n (1) 4-bromo-2, 5-dimethoxy-amphetamine Some trade or other names:\n4-bromo-2, 5-dimethoxy-@-methylphenethylamine; 4-bromo-2, 5-DMA.\n (2) 2, 5-dimethoxyamphetamine Some trade or other names:\n2, 5-dimethoxy-@-methylphenethylamine; 2, 5-DMA.\n (3) 4-methoxyamphetamine Some trade or other names:\n4-methoxy-@-methylphenethylamine; paramethoxyamphetamine, PMA.\n (4) 5-methoxy-3, 4-methylenedioxy - amphetamine.\n (5) 4-methyl-2, 5-dimethoxy-amphetamine Some trade and other names:\n4-methyl-2, 5-dimethoxy-@-methylphenethylamine; "DOM"; and "STP".\n (6) 3, 4-methylenedioxy amphetamine.\n (7) 3, 4, 5-trimethoxy amphetamine.\n (8) Bufotenine Some trade and other names: 3-(&-dimethylaminoethyl)-5\nhydroxindole; 3-(2-dimethylaminoethyl)- 5-indolol;\nN, N-dimethylserotonin; -5-hydroxy-N, N-dimethyltryptamine; mappine.\n (9) Diethyltryptamine Some trade and other names:\nN, N-diethyltryptamine; DET.\n (10) Dimethyltryptamine Some trade or other names: DMT.\n (11) Ibogane Some trade and other names: 7-ethyl-6, 6&, 7, 8, 9, 10,\n12, 13-octahydro-2-methoxy-6, 9-methano-5h-pyrido {1',2':1,2} azepino\n{5,4-b} indole: tabernanthe iboga.\n (12) Lysergic acid diethylamide.\n (13) Mescaline.\n (14) Parahexyl. Some trade or other names: 3-Hexyl-1-hydroxy-\n7,8,9,10-tetra hydro-6,6,9-trimethyl-6H-dibenfo{b,d} pyran.\n (15) Peyote. Meaning all parts of the plant presently classified\nbotanically as Lophophora williamsii Lemaire, whether growing or not,\nthe seeds thereof, any extract from any part of such plant, and every\ncompound, manufacture, salts, derivative, mixture, or preparation of\nsuch plant, its seeds or extracts.\n (16) N-ethyl-3-piperidyl benzilate.\n (17) N-methyl-3-piperidyl benzilate.\n (18) Psilocybin.\n (19) Psilocyn.\n (20) Tetrahydrocannabinols. Synthetic tetrahydrocannabinols not\nderived from the cannabis plant that are equivalents of the substances\ncontained in the plant, or in the resinous extractives of cannabis, sp.\nand/or synthetic substances, derivatives, and their isomers with similar\nchemical structure and pharmacological activity such as the following:\n delta 1 cis or trans tetrahydrocannabinol, and their optical isomers\n delta 6 cis or trans tetrahydrocannabinol, and their optical isomers\n delta 3, 4 cis or trans tetrahydrocannabinol, and its optical isomers\n(since nomenclature of these substances is not internationally\nstandardized, compounds of these structures, regardless of numerical\ndesignation of atomic positions covered). Any Federal Food and Drug\nAdministration approved product containing tetrahydrocannabinol shall\nnot be considered a synthetic tetrahydrocannabinol.\n (21) Ethylamine analog of phencyclidine. Some trade or other names:\nN-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine,\nN-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE.\n (22) Pyrrolidine analog of phencyclidine. Some trade or other names\n1-(1-phenylcyclohexyl)-pyrrolidine; PCPy, PHP.\n (23) Thiophene analog of phencyclidine. Some trade or other names:\n1-{1-(2-thienyl)-cyclohexyl}-piperidine, 2-thienylanalog of\nphencyclidine, TPCP, TCP.\n (24) 3,4-methylenedioxymethamphetamine (MDMA).\n (25) 3,4-methylendioxy-N-ethylamphetamine (also known as\nN-ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA,\nMDE, MDEA.\n (26) N-hydroxy-3,4-methylenedioxyamphetamine (also known as\nN-hydroxy-alpha-methyl-3,4 (methylenedioxy) phenethylamine, and\nN-hydroxy MDA.\n (27) 1-{1- (2-thienyl) cyclohexyl} pyrrolidine. Some other names:\nTCPY.\n (28) Alpha-ethyltryptamine. Some trade or other names: etryptamine;\nMonase; Alpha-ethyl-1H-indole-3-ethanamine; 3- (2-aminobutyl) indole;\nAlpha-ET or AET.\n (29) 2,5-dimethoxy-4-ethylamphetamine. Some trade or other names:\nDOET.\n (30) 4-Bromo-2,5-dimethoxyphenethylamine. Some trade or other names:\n2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB;\n2C-B, Nexus.\n (31) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its\noptical isomers, salts and salts of isomers.\n (33) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,\nalso known as 25I-NBOMe; 2C-I-NBOMe; 25I; or Cimbi-5.\n (34) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,\nalso known as 25 CNBOMe; 2C-C-NBOMe; 25C; or Cimbi-82.\n (35) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,\nalso known as, 25 BNBOMe; 2C-B-NBOMe; Cimbi-36.\n (36) 5-methoxy-N,N-dimethyltryptamine.\n (37) Alpha-methyltryptamine. Some trade or other names: AMT.\n (38) 5-methoxy-N,N-diisopropyltryptamine. Some trade or other names:\n5-MeO-DIPT.\n (e) Depressants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a depressant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers whenever the existence of such salts, isomers, and\nsalts of isomers is possible within the specific chemical designation:\n (1) Mecloqualone.\n (2) Methaqualone.\n (3) Phencyclidine.\n (4) Gamma hydroxybutyric acid, and salt, hydroxybutyric compound,\nderivative or preparation of gamma hydroxybutyric acid, including any\nisomers, esters and ethers and salts of isomers, esters and ethers of\ngamma hydroxybutyric acid, except gamma-butyrolactone, whenever the\nexistence of such isomers, esters and ethers and salts is possible\nwithin the specific chemical.\n (5) Gamma-butyrolactone, including butyrolactone; butyrolactone gamma;\n4-butyrolactone; 2(3H)-furanone dihydro; dihydro-2(3H)-furanone;\ntetrahydro-2-furanone; 1,2-butanolide; 1,4-butanolide; 4-butanolide;\ngamma-hydroxybutyric acid lactone; 3-hydroxybutyric acid lactone and\n4-hydroxybutanoic acid lactone with Chemical Abstract Service number\n(96-48-0) when any such substance is intended for human consumption.\n (6) 1,4 butanediol, including butanediol; butane-1,4-diol;\n1,4-butylene glyco; butylene glycol; 1,4-dihydroxybutane;\n1,4-tetramethylene glycol; tetramethylene glycol; tetramethylene\nAbstract Service number (110-63-4) when any such substance is intended\nfor human consumption.\n (f) Stimulants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a stimulant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers:\n (1) Fenethylline.\n (2) N-ethylamphetamine.\n (3) (+ -)cis-4-methylaminorex ((+ -)cis-4,5-dihydro-4-methyl -5-phenyl\n-2-oxazolamine).\n (4) N,N-dimethylamphetamine (also known as N,N-alpha-\ntrimethyl-benzeneethanamine; N,N-alpha- trimethylphenethylamine).\n (5) Methcathinone (some other names: 2-(methylamino) - propiophenone;\nalpha-(methylamino) propiophenone; 2-(methylamino) -1-phenylpropan-\n1-one; alpha-N- methylaminopropiophenone; monomethylpropion; ephedrone,\nN-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and UR1432),\nits salts, optical isomers and salts of optical isomers.\n (6) Aminorex. Some other names: aminoxaphen; 2-amino-5-phenyl\n-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine.\n (7) Cathinone. Some trade or other names:\n2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone,\n2-aminopropiophenone, and norephedrone.\n (8) N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine),\nits optical isomers, salts and salts of isomers.\n (9) 4-methyl-N-methylcathinone or 4-Methylmethcathinone, also known as\nMephedrone.\n (10) 3,4-methylenedioxypyrovalerone or Methylenedioxypyrovalerone,\nalso known as MDPV.\n (11) 3,4-methylenedioxy-N-methylcathinone (some other names:\nmethylone).\n (12) 4-Methoxymethcathinone.\n (13) 3-Fluoromethcathinone.\n (14) 4-Fluoromethcathinone.\n (15) Ethylpropion (Ethcathinone).\n (16) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).\n (17) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).\n (18) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).\n (19) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).\n (20) 2-{4-(Ethylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-2).\n (21) 2-{4-(Isopropylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-4).\n (22) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).\n (23) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).\n (24) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).\n (g) Synthetic cannabinoids. Unless specifically excepted or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation, which contains any quantity of the following synthetic\ncannabinoid substances, or which contains any of its salts, isomers, and\nsalts of isomers whenever the existence of such salts, isomers, and\nsalts of isomers is possible within the specific chemical designation\n(for purposes of this paragraph only, the term "isomer" includes the\noptical, position and geometric isomers):\n (1) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)\nmethanone. Some trade or other names: UR-144.\n (2) {1-(5-fluro-pentyl)-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)\nmethanone. Some trade names or other names: 5-fluoro-UR-144, XLR11.\n (3) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide. Some trade or\nother names: APINACA, AKB48.\n (4) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate. Some trade or\nother names: PB-22; QUPIC.\n (5) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. Some\ntrade or other names: 5-fluoro-PB-22; 5F-PB-22.\n (6) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazo-\nle-3-carboxamide. Some trade or other names: AB-FUBINACA.\n (7) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-\ncarboxamide. Some trade or other names: ADB-PINACA.\n (8) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-\nindazole-3-carboxamide. Some trade or other names: AB-CHMINACA.\n (9) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-\ncarboxamide. Some trade or other names: AB-PINACA.\n (10) {1-(5-fluoropentyl)-1H-indazol-3-yl}(naphthalen-1-y1)methanone.\nSome trade or other names: THJ-2201.\n (h) (1) Cannabimimetic agents. Unless specifically exempted or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation that is not approved by the federal food and drug\nadministration (FDA) which contains any quantity of cannabimimetic\nagents, or which contains their salts, isomers, and salts of isomers\nwhenever the existence of such salts, isomers, and salts of isomers is\npossible within the specific chemical designation.\n (2) As used in this subdivision, the term "cannabimimetic agents"\nmeans any substance that is a cannabinoid receptor type 1 (CB1 receptor)\nagonist as demonstrated by binding studies and functional assays within\nany of the following structural classes:\n (i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position\nof the phenolic ring by alkyl or alkenyl, whether or not substituted on\nthe cyclohexyl ring to any extent.\n (ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by\nsubstitution at the nitrogen atom of the indole ring, whether or not\nfurther substituted on the indole ring to any extent, whether or not\nsubstituted on the naphthoyl or naphthyl ring to any extent.\n (iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of\nthe pyrrole ring, whether or not further substituted in the pyrrole ring\nto any extent, whether or not substituted on the naphthoyl ring to any\nextent.\n (iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position\nof the indene ring, whether or not further substituted in the indene\nring to any extent, whether or not substituted on the naphthyl ring to\nany extent.\n (v) 3-phenylacetylindole or 3-benzoylindole by substitution at the\nnitrogen atom of the indole ring, whether or not further substituted in\nthe indole ring to any extent, whether or not substituted on the phenyl\nring to any extent.\n (3) Such term includes:\n (i) 5-(1,1-dimethylheptyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol\n(CP-47,497);\n (ii) 5-(1,1-dimethyloctyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol\n(cannabicyclohexanol or CP-47,497 C8-homolog);\n (iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);\n (iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);\n (v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);\n (vi) 1-{2-(4-morpholinyl)ethyl}-3-(1-naphthoyl)indole (JWH-200);\n (vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);\n (viii) 1-pentyl-3-{1-(4-methoxynaphthoyl)}indole (JWH-081);\n (ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);\n (x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);\n (xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);\n (xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);\n (xiii) 1-pentyl-3-{(4-methoxy)-benzoyl}indole (SR-19 and RCS-4);\n (xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and\nRCS-8); and\n (xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).\n Schedule II. (a) Schedule II shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n (b) Substances, vegetable origin or chemical synthesis. Unless\nspecifically excepted or unless listed in another schedule, any of the\nfollowing substances whether produced directly or indirectly by\nextraction from substances of vegetable origin, or independently by\nmeans of chemical synthesis, or by a combination of extraction and\nchemical synthesis:\n (1) Opium and opiate, and any salt, compound, derivative, or\npreparation of opium or opiate, excluding apomorphine, dextrorphan,\nnalbuphine, nalmefene, naloxone, and naltrexone, and their respective\nsalts, but including the following:\n 1. Raw opium.\n 2. Opium extracts.\n 3. Opium fluid.\n 4. Powdered opium.\n 5. Granulated opium.\n 6. Tincture of opium.\n 7. Codeine.\n 8. Ethylmorphine.\n 9. Etorphine hydrochloride.\n 10. Hydrocodone (also known as dihydrocodeinone).\n 11. Hydromorphone.\n 12. Metopon.\n 13. Morphine.\n 14. Oxycodone.\n 15. Oxymorphone.\n 16. Thebaine.\n 17. Dihydroetorphine.\n 18. Oripavine.\n (2) Any salt, compound, derivative, or preparation thereof which is\nchemically equivalent or identical with any of the substances referred\nto in this section, except that these substances shall not include the\nisoquinoline alkaloids of opium.\n (3) Opium poppy and poppy straw.\n (4) Coca leaves and any salt, compound, derivative, or preparation of\ncoca leaves, and any salt, compound, derivative, or preparation thereof\nwhich is chemically equivalent or identical with any of these substances\nincluding cocaine and ecgonine, their salts, isomers, and salts of\nisomers, except that the substances shall not include: (A) decocainized\ncoca leaves or extraction of coca leaves, which extractions do not\ncontain cocaine or ecgonine; or (B) {123I} ioflupane.\n (5) Concentrate of poppy straw (the crude extract of poppy straw in\neither liquid, solid or powder form which contains the phenanthrene\nalkaloids of the opium poppy).\n (b-1) Unless specifically excepted or unless listed in another\nschedule, any material, compound, mixture, or preparation containing any\nof the following, or their salts calculated as the free anhydrous base\nor alkaloid, in limited quantities as set forth below:\n (1) Not more than three hundred milligrams of dihydrocodeinone\n(hydrocodone) per one hundred milliliters or not more than fifteen\nmilligrams per dosage unit, with a fourfold or greater quantity of an\nisoquinoline alkaloid of opium.\n (2) Not more than three hundred milligrams of dihydrocodeinone\n(hydrocodone) per one hundred milliliters or not more than fifteen\nmilligrams per dosage unit, with one or more active nonnarcotic\ningredients in recognized therapeutic amounts.\n (c) Opiates. Unless specifically excepted or unless in another\nschedule any of the following opiates, including its isomers, esters,\nethers, salts and salts of isomers, esters and ethers whenever the\nexistence of such isomers, esters, ethers, and salts is possible within\nthe specific chemical designation, dextrorphan and levopropoxyphene\nexcepted:\n (1) Alfentanil.\n (2) Alphaprodine.\n (3) Anileridine.\n (4) Bezitramide.\n (5) Bulk dextropropoxyphene (non-dosage forms).\n (6) Carfentanil.\n (7) Dihydrocodeine.\n (8) Diphenoxylate.\n (9) Fentanyl.\n (10) Isomethadone.\n (11) Levo-alphacetylmethadol (also known as levo-alpha-acetylmethadol,\nlevomethadylacetate or LAAM).\n (12) Levomethorphan.\n (13) Levorphanol.\n (14) Metazocine.\n (15) Methadone.\n (16) Methadone-intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl\nbutane.\n (17) Moramide-intermediate, 2-methyl-3-morpholino-1,\n1--diphenylpropane--carboxylic acid.\n (18) Pethidine (meperidine).\n (19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine.\n (20) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate.\n (21) Pethidine-intermediate-C, 1--methyl--4-- phenylpiperidine--4--\ncarboxylic acid.\n (22) Phenazocine.\n (23) Piminodine.\n (24) Racemethorphan.\n (25) Racemorphan.\n (26) Sufentanil.\n (27) Remifentanil.\n (28) Tapentadol.\n (29) Thiafentanil.\n (d) Stimulants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a stimulant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers:\n (1) Amphetamine.\n (2) Methamphetamine.\n (3) Phenmetrazine.\n (4) Methylphenidate.\n (5) Lisdexamfetamine.\n (e) Depressants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a depressant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers whenever the existence of such salts, isomers, and\nsalts of isomers is possible within the specific chemical designation:\n (1) Amobarbital.\n (2) Glutethimide.\n (3) Pentobarbital.\n (4) Secobarbital.\n (f) Hallucinogenic substances.\n Nabilone: Another name for nabilone: (+,-)-trans\n-3-(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6,\n6-dimethyl-9H-dibenzo{b,d}pyran-9-one.\n (g) Immediate precursors. Unless specifically excepted or unless\nlisted in another schedule, any material, compound, mixture or\npreparation which contains any quantity of the following substances:\n (1) Immediate precursor to amphetamine and methamphetamine:\n (i) Phenylacetone Some trade or other names: pheny1-2-propanone; P2P;\nbenzyl methyl ketone; methyl benzyl ketone;\n (2) Immediate precursors to phencyclidine (PCP):\n (i) 1-phenylcyclohexylamine;\n (ii) 1-piperidinocyclohexanecarbonitrile (PCC).\n (3) Immediate precursor to fentanyl:\n (i) 4-anilino-N-phenenethylpiperidine (ANPP).\n (ii) N-phenyl-N-(piperidin-4-yl)propionamide (Norfentanyl).\n (h) Anabolic steroids. Unless specifically excepted or unless listed\nin another schedule, "anabolic steroid" shall mean any drug or hormonal\nsubstance, chemically and pharmacologically related to testosterone\n(other than estrogens, progestins, corticosteroids and\ndehydroepiandrosterone) and includes:\n (1) 3{beta}, 17-dihydroxy-5a-androstane.\n (2) 3{alpha}, 17{beta}-dihydroxy-5a-androstane.\n (3) 5{alpha}-androstan-3,17-dione.\n (4) 1-androstenediol (3{beta},17{beta}-dihydroxy-5{alpha}-androst-1-\nene).\n (5) 1-androstenediol (3{alpha},17{beta}-dihydroxy-5{alpha}-androst-1-\nene).\n (6) 4-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-4-ene).\n (7) 5-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-5-ene).\n (8) 1-androstenedione ({5{alpha}}-androst-1-en-3,17-dione).\n (9) 4-androstenedione (androst-4-en-3,17-dione).\n (10) 5-androstenedione (androst-5-en-3,17-dione).\n (11) Bolasterone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyandrost-\n4-en-3-one).\n (12) Boldenone (17{beta}-hydroxyandrost-1, 4,-diene-3-one).\n (13) Boldione (androsta-1,4-diene-3,17-dione).\n (14) Calusterone (7{beta}, 17{alpha}-dimethyl-17{beta}-hydroxyandrost-\n4-en-3-one).\n (15) Clostebol (4-chloro-17{beta}-hydroxyandrost-4-en-3-one).\n (16) Dehydrochloromethyltestosterone (4-chloro-17{beta}-hydroxy-17\n{alpha}-methyl-androst-1, 4-dien-3-one).\n (17) {Delta} 1-dihydrotestosterone (a.k.a. '1-testosterone') (17\n{beta}-hydroxy-5{alpha}-androst-1-en-3-one).\n (18) 4-dihydrotestosterone (17{beta}-hydroxy-androstan-3-one).\n (19) Drostanolone (17{beta}-hydroxy-2{alpha}-methyl-5{alpha}\n-androstan-3-one).\n (20) Ethylestrenol (17{alpha}-ethyl-17{beta}-hydroxyestr- 4-ene).\n (21) Fluoxymesterone (9-fluoro-17{alpha}-methyl-11{beta}, 17 {beta}-\ndihydroxyandrost-4-en-3-one).\n (22) Formebolone (2-formyl-17{alpha}-methyl-11{alpha},\n17{beta}-dihydroxyandrost-1, 4-dien-3-one).\n (23) Furazabol (17{alpha}-methyl-17{beta}-hydroxyandrostano\n{2, 3-c}-furazan).\n (24) 13{beta}-ethyl-17{beta}-hyroxygon-4-en-3-one.\n (25) 4-hydroxytestosterone (4, 17{beta}-dihydroxy-androst-4-en-3-one).\n (26) 4-hydroxy-19-nortestosterone\n(4,17{beta}-dihydroxy-estr-4-en-3-one).\n (27) desoxymethyltestosterone\n(17{alpha}-methyl-5{alpha}-androst-2-en-17{beta}-ol) (a.k.a., madol).\n (28) Mestanolone (17{alpha}-methyl-17{beta}-hydroxy-\n5-androstan-3-one).\n (29) Mesterolone (1{alpha} methyl-17{beta}-hydroxy-\n{5{alpha}}-androstan-3-one).\n (30) Methandienone (17{alpha}-methyl-17{beta}-hydroxyandrost-1,\n4-dien-3-one).\n (31) Methandriol (17{alpha}-methyl-3{beta},\n17{beta}-dihydroxyandrost-5-ene).\n (32) Methenolone (1-methyl-17{beta}-hydroxy-5{alpha}-androst-\n1-en-3-one).\n (33) 17{alpha}-methyl-3{beta},17{beta}-dihydroxy-5a-androstane.\n (34) 17{alpha}-methyl-3{alpha}, 17{beta}-dihydroxy- 5a-androstane.\n (35) 17{alpha}-methyl-3{beta}, 17{beta}-dihydroxyandrost-4-ene.\n (36) 17{alpha}-methyl-4-hydroxynandrolone (17{alpha}-methyl-4-\nhydroxy-17{beta}-hydroxyestr-4-en-3-one).\n (37) Methyldienolone (17{alpha}-methyl-17{beta}-hydroxyestra-\n4,9(10)-dien-3-one).\n (38) Methyltrienolone (17{alpha}-methyl-17{beta}-hydroxyestra-4,\n9-11-trien-3-one).\n (39) Methyltestosterone (17{alpha}-methyl-17{beta}-hydroxyandrost-\n4-en-3-one).\n (40) Mibolerone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyestr-\n4-en-3-one).\n (41) 17{alpha}-methyl-{Delta} 1-dihydrotestosterone\n(17b{beta}-hydroxy-17{alpha}-methyl-5{alpha}-androst-1-en-3-one)\n(a.k.a. '17-{alpha}-methyl-1-testosterone').\n (42) Nandrolone(17{beta}-hydroxyestr-4-en-3-one).\n (43) 19-nor-4-androstenediol (3{beta},17{beta}-dihydroxyestr -4-ene).\n (44) 19-nor-4-androstenediol (3{alpha},17{beta}-dihydroxyestr-4-ene).\n (45) 19-nor-5-androstenediol (3{beta},17{beta}-dihydroxyestr -5-ene).\n (46) 19-nor-5-androstenediol (3{alpha},17{beta}-dihydroxyestr-5-ene).\n (47) 19-nor-4,9(10)-androstadienedione\n(estra-4,9(10)-diene-3,17-dione).\n (48) 19-nor-4-androstenedione (estr-4-en-3,17-dione).\n (49) 19-nor-5-androstenedione (estr-5-en-3,17-dione).\n (50) Norbolethone (13{beta}, 17{alpha}-diethyl-17{beta}\n-hydroxygon-4-en-3-one).\n (51) Norclostebol (4-chloro-17{beta}-hydroxyestr-4-en-3-one).\n (52) Norethandrolone (17{alpha}-ethyl-17{beta}-hydroxyestr-\n4-en-3-one).\n (53) Normethandrolone (17{alpha}-methyl-17{beta}\n-hydroxyestr-4-en-3-one).\n (54) Oxandrolone (17{alpha}-methyl-17{beta}-hydroxy-2-oxa-\n{5{alpha}}-androstan-3-one).\n (55) Oxymesterone (17{alpha}-methyl-4, 17{beta}-dihydroxy\nandrost-4-en-3-one).\n (56) Oxymetholone (17 {alpha}-methyl-2-hydroxymethylene-17\n{beta}-hydroxy-{5{alpha}}- androstan-3-one).\n (57) Stanozolol (17{alpha}-methyl-17{beta}-hydroxy-{5{alpha}}-\nandrost-2-eno{3, 2-c}-pyrazole).\n (58) Stenbolone (17{beta}-hydroxy-2-methyl-{5{alpha}}-androst-\n1-en-3-one).\n (59) Testolactone (13-hydroxy-3-oxo-13, 17-secoandrosta-1,\n4-dien-17-oic acid lactone).\n (60) Testosterone (17{beta}-hydroxyandrost-4-en-3-one).\n (61) Tetrahydrogestrinone (13{beta}, 17{alpha}-diethyl\n-17{beta}-hydroxygon-4, 9, 11-trien-3-one).\n (62) Trenbolone (17{beta}-hydroxyestr-4, 9, 11-trien-3-one).\n (63) Any salt, ester or ether of a drug or substance described or\nlisted in this subdivision.\n (i) Subdivision (h) of this section shall not include any substance\ncontaining anabolic steroids expressly intended for administration\nthrough implants to cattle or other nonhuman species and that are\napproved by the federal food and drug administration solely for such\nuse. Any individual who knowingly and willfully administers to himself\nor another person, prescribes, dispenses or distributes such substances\nfor other than implantation to cattle or nonhuman species shall be\nsubject to the same penalties as a practitioner who violates the\nprovisions of this section or any other penalties prescribed by law.\n Schedule III. (a) Schedule III shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n (b) Stimulants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a stimulant\neffect on the central nervous system, including its salts, isomers\n(whether optical, position, or geometric), and salts of such isomers\nwhenever the existence of such salts, isomers, and salts of isomers is\npossible within the specific chemical designation:\n (1) Those compounds, mixtures, or preparations in dosage unit form\ncontaining any stimulant substances listed in schedule II which\ncompounds, mixtures, or preparations were listed on August twenty-five,\nnineteen hundred seventy-one, as excepted compounds under title\ntwenty-one, section 308.32 of the code of federal regulations and any\nother drug of the quantitive composition shown in that list for those\ndrugs or which is the same except that it contains a lesser quantity of\ncontrolled substances.\n (2) Benzphetamine.\n (3) Chlorphentermine.\n (4) Clortermine.\n (6) Phendimetrazine.\n (c) Depressants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a depressant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers:\n (1) Any compound, mixture or preparation containing:\n (i) Amobarbital;\n (ii) Secobarbital;\n (iii) Pentobarbital;\nor any salt thereof and one or more other active medicinal ingredients\nwhich are not listed in any schedule.\n (2) Any suppository dosage form containing:\n (i) Amobarbital;\n (ii) Secobarbital;\n (iii) Pentobarbital;\nor any salt of any of these drugs and approved by the federal food and\ndrug administration for marketing only as a suppository.\n (3) Any substance which contains any quantity of a derivative of\nbarbituric acid or any salt thereof.\n (4) Chlorhexadol.\n (5) Lysergic acid.\n (6) Lysergic acid amide.\n (7) Methyprylon.\n (8) Sulfondiethylmethane.\n (9) Sulfonethylmethane.\n (10) Sulfonmethane.\n (11) Tiletamine and zolazepam or any salt thereof. Some trade or other\nnames for a tiletamine-zolazepam combination product: Telazol. Some\ntrade or other names for tiletamine: 2-(ethylamino) -2-(2-thienyl)\n-cyclohexanone. Some trade or other names for zolazepam:\n4-(2-fluorophenyl) -6,8-dihydro -1, 3, 8i-trimethylpyrazolo-{3,4-e}\n{1,4} -diazepin-7(1H)-one, flupyrazapon.\n (12) Gamma hydroxybutyric acid, and salt, hydroxybutyric compound,\nderivative or preparation of gamma hydroxybutyric acid, including any\nisomers, esters and ethers and salts of isomers, esters and ethers of\ngamma hydroxybutyric acid, contained in a drug product for which an\napplication has been approved under section 505 of the federal food,\ndrug and cosmetic act.\n (13) Ketamine, its salts, isomers and salts of isomers (some\nother names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-\ncyclohexanone).\n (14) Embutramide.\n (d) Nalorphine.\n (e) Narcotic drugs. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation\ncontaining any of the following narcotic drugs, or their salts\ncalculated as the free anhydrous base or alkaloid, in limited quantities\nas set forth below:\n (1) Not more than 1.8 grams of codeine per one hundred milliliters or\nnot more than ninety milligrams per dosage unit, with an equal or\ngreater quantity of an isoquinoline alkaloid of opium.\n (2) Not more than 1.8 grams of codeine per one hundred milliliters or\nnot more than ninety milligrams per dosage unit, with one or more\nactive, nonnarcotic ingredients in recognized therapeutic amounts.\n (3) Not more than 1.8 grams of dihydrocodeine per one hundred\nmilliliters or not more than ninety milligrams per dosage unit, with one\nor more active nonnarcotic ingredients in recognized therapeutic\namounts.\n (4) Not more than three hundred milligrams of ethylmorphine per one\nhundred milliliters or not more than fifteen milligrams per dosage unit,\nwith one or more active, nonnarcotic ingredients in recognized\ntherapeutic amounts.\n (5) Not more than five hundred milligrams of opium per one hundred\nmilliliters or per one hundred grams or not more than twenty-five\nmilligrams per dosage unit, with one or more active, nonnarcotic\ningredients in recognized therapeutic amounts.\n (6) Not more than fifty milligrams of morphine per one hundred\nmilliliters or per one hundred grams, with one or more active,\nnonnarcotic ingredients in recognized therapeutic amounts.\n (7) Buprenorphine in any quantities.\n (f) Dronabinol (synthetic) in sesame oil and encapsulated in a soft\ngelatin capsule in a U.S. Food and Drug Administration approved product.\n Some other names for dronabinol include: (6aR-trans)-6a, 7, 8,\n10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo{b,d} pyran-1-o1, or\n(-)-delta-9-(trans) - tetrahydrocannabinol.\n (g) Chorionic gonadotropin. (1) Unless specifically excepted or unless\nlisted in another schedule any material, compound, mixture, or\npreparation which contains any amount of chorionic gonadotropin.\n (2) Paragraph one of this subdivision shall not include any substance\ncontaining chorionic gonadotropin expressly intended for administration\nthrough implants or injection to cattle or other nonhuman species and\nthat are approved by the federal food and drug administration solely for\nsuch use. Any individual who knowingly and willfully administers to\nhimself or another person, prescribes, dispenses or distributes such\nsubstances for other than implantation or injection to cattle or\nnonhuman species shall be subject to the same penalties as a\npractitioner who violates the provisions of this section or any other\npenalties prescribed by law.\n Schedule IV. (a) Schedule IV shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n (b) Narcotic drugs. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation\ncontaining any of the following narcotic drugs, or their salts\ncalculated as the free anhydrous base or alkaloid, in limited quantities\nas set forth below:\n (1) Not more than one milligram of difenoxin and not less than\ntwenty-five micrograms of atropine sulfate per dosage unit.\n (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-\nmethyl-2-propionoxybutane).\n (c) Depressants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances, including its salts,\nisomers, and salts of isomers whenever the existence of such salts,\nisomers, and salts of isomers is possible within the specific chemical\ndesignation:\n (1) Alprazolam.\n (2) Barbital.\n (3) Bromazepam.\n (4) Camazepam.\n (5) Chloral betaine.\n (6) Chloral hydrate.\n (7) Chlordiazepoxide.\n (8) Clobazam.\n (9) Clonazepam.\n (10) Clorazepate.\n (11) Clotiazepam.\n (12) Cloxazolam.\n (13) Delorazepam.\n (14) Diazepam.\n (15) Estazolam.\n (16) Ethchlorvynol.\n (17) Ethinamate.\n (18) Ethyl Loflazepate.\n (19) Fludiazepam.\n (20) Flunitrazepam.\n (21) Flurazepam.\n (22) Halazepam.\n (23) Haloxazolam.\n (24) Ketazolam.\n (25) Loprazolam.\n (26) Lorazepam.\n (27) Lormetazepam.\n (28) Mebutamate.\n (29) Medazepam.\n (30) Meprobamate.\n (31) Methohexital.\n (32) Methylphenobarbital (mephobarbital).\n (33) Nimetazepam.\n (34) Nitrazepam.\n (35) Nordiazepam.\n (36) Oxazepam.\n (37) Oxazolam.\n (38) Paraldehyde.\n (39) Petrichoral.\n (40) Phenobarbital.\n (41) Pinazepam.\n (42) Prazepam.\n (43) Temazepam.\n (44) Tetrazepam.\n (45) Triazolam.\n (46) Midazolam.\n (47) Quazepam.\n (48) Zolpidem.\n (49) Dichloralphenazone.\n (50) Zaleplon.\n (51) Zopiclone (eszopiclone).\n (52) Fospropofol.\n (53) Carisoprodol.\n * (d) Fenfluramine. Any material, compound, mixture, or preparation\nwhich contains any quantity of the following substances, including its\nsalts, isomers (whether optical, position, or geometric), and salts of\nsuch isomers, whenever the existence of such salts, isomers and salts of\nisomers is possible:\n (1) Fenfluramine.\n * NB Repealed upon the removal of fenfluramine and its salts and\nisomers from Schedule IV of the federal Controlled Substances Act\n (e) Stimulants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a stimulant\neffect on the central nervous system, including its salts, isomers, and\nsalts of such isomers:\n (1) Cathine ((+) - norpseudoephedrine).\n (2) Diethylpropion.\n (3) Fencamfamin.\n (4) Fenproporex.\n (5) Mazindol.\n (6) Mefenorex.\n (7) Pemoline (including organometallic complexes and chelates\nthereof).\n (8) Phentermine.\n (9) Pipradrol.\n (10) SPA((-))-1-dimethylamino-1, 2-diphenylethane).\n (11) Modafinil.\n (12) Sibutramine.\n (f) Other substances. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture or preparation which\ncontains any quantity of the following substances, including its salts:\n (1) Pentazocine.\n (2) Butorphanol (including its optical isomers).\n (3) Tramadol in any quantities.\n Schedule V. (a) Schedule V shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n (b) Narcotic drugs containing nonnarcotic active medicinal\ningredients. Any compound, mixture, or preparation containing any of\nthe following narcotic drugs, or their salts calculated as the free\nanhydrous base or alkaloid, in limited quantities as set forth below,\nwhich shall include one or more nonnarcotic active medicinal ingredients\nin sufficient proportion to confer upon the compound, mixture, or\npreparation valuable medicinal qualities other than those possessed by\nnarcotic drugs alone:\n (1) Not more than two hundred milligrams of codeine per one hundred\nmilliliters or per one hundred grams.\n (2) Not more than one hundred milligrams of dihydrocodeine per one\nhundred milliliters or per one hundred grams.\n (3) Not more than one hundred milligrams of ethylmorphine per one\nhundred milliliters or per one hundred grams.\n (4) Not more than 2.5 milligrams of diphenoxylate and not less than\ntwenty-five micrograms of atropine sulfate per dosage unit.\n (5) Not more than one hundred milligrams of opium per one hundred\nmilliliters or per one hundred grams.\n (6) Not more than 0.5 milligram of difenoxin and not less than\ntwenty-five micrograms of atropine sulfate per dosage unit.\n (c) Stimulants. Unless specifically exempted or excluded or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation which contains any quantity of the following substances\nhaving a stimulant effect on the central nervous system, including its\nsalts, isomers and salts of isomers:\n (1) Pyrovalerone.\n (d) Depressants. Unless specifically exempted or excluded or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation which contains any quantity of the following substances\nhaving a depressant effect on the central nervous system, including its\nsalts, isomers, and salts of isomers:\n (1) Ezogabine {N-{2-amino-4-(4-fluorobenzylamino)-phenyl}-carbamic\nacid ethyl ester}.\n (2) Lacosamide {(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide}.\n (3) Pregabalin {(S)-3-(aminomethyl)-5-methylhexanoic acid }.\n